Iryna Leunikava

Non-interventional studies/RWD Lead, EU Neurology
UCB Pharma

Presentation(s):

• PB0340 - Treatment by Line in Patients With Persistent and Chronic Immune Thrombocytopenia, A Real-World Point-In-Time Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM